| Identification | |
| Name: | Imatinib mesylate |
| Synonyms: | Benzamide, 4-[ (4-methyl-1-piperazinyl)methyl]-N-[[4- methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-, monomethanesulfonate;Matinib mesylate;Imatinib Methanesulfonate;Imatinibmesylate & its intermediates;4-(4-Methyl-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide methanesulfonic acid salt;Veenat;4-(4-Methyl-piperazin-1-ylmethyl)-N-[4-methyl-3- (4-pyridin-3-yl)-pyrimidin-2-ylamino)-phenyl]-benzamidemethanesulf onic acid salt;methanesulfonic acid; 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide; |
| CAS: | 220127-57-1 |
| Molecular Formula: | C29H31N7O.CH4O3S |
| Molecular Weight: | 589.7084 |
| InChI: | InChI=1S/C29H31N7O.CH4O3S/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36;1-5(2,3)4/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34);1H3,(H,2,3,4) |
| Molecular Structure: | ![(C29H31N7O.CH4O3S) Benzamide, 4-[ (4-methyl-1-piperazinyl)methyl]-N-[[4- methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino...](https://img.guidechem.com/casimg/220127-57-1.gif) |
| Properties | |
| Flash Point: | 410.3 oC |
| Boiling Point: | 754.9 oC at 760 mmHg |
| Water Solubility: | Freely soluble in DMSO and soluble in water |
| Solubility: | Freely soluble in DMSO and soluble in water |
| Appearance: | white crystalline powder . |
| Specification: |
?Imatinib mesylate (CAS NO.220127-57-1), its Synonyms are Benzamide, 4-((4-methyl-1-piperazinyl)methyl)-N-(4-methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)phenyl)-, monomethanesulfonate ; 4-[(4-methylpiperazin-1-yl)methyl]-n-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide methanesulfonate ; 4-[(4-methyl-1-piperazinyl)methyl]-n-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide monomethanesulfonate . It is off-white solid. |
| Flash Point: | 410.3 oC |
| Color: | White to off white to brownish or yellowish tinged crystalline powder |
| Usage: | Imatinib intermediates |
| Safety Data | |
 |
|
